ArticleBlood cancer journal2023

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.

Pallawi Torka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.